Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.
Clinical trial NCT05284799 · COMPLETED
Trial details
- NCT number
- NCT05284799
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2022-07-19
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.